STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease
- Sponsor
- Radboud University Medical Center
- Study ID
- NCT04848077
- Status
- Recruiting
Conditions
- Movement Disorders
- Parkinson Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Step count increase with the use of a motivational smartphone application — BEHAVIORALAll participants will be given access to an application installed on the participants' own smartphone: the STEPWISE app. The STEPWISE app will encourage participants to increase their long-term physical activity (1 year). Different treatment arms will receive different physical activity goals. Participants will get feedback and support via the smartphone app, that stimulates them to reach their individual physical activity goal (i.e. target percentage increase in stepcount).
Study Details
The aim of this study is to investigate whether a smartphone app can increase physical activity in patients with Parkinson's Disease in daily life for a long period of time (12 months).
Key Dates
- First listed
- Apr 19, 2021
- Start date
- May 18, 2021
- Status verified
- Nov 2024
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 452 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Very high doseVery large proportional increase in stepcount relative to baseline stepcount.
- Experimental: High doseLarge proportional increase in stepcount relative to baseline stepcount.
- Experimental: Intermediate doseMedium proportional increase in stepcount relative to baseline stepcount.
- Active Comparator: Active controlsSmall proportional increase in stepcount relative to baseline stepcount.
Primary Outcome Measure
Mean change in step count per day [ Time Frame: Week -4 until 0 and week 49 until 52 ]
Central Contacts
- Sabine Schootemeijer, MSc00316 50155754
Find similar trials
Related Studies
- Botulinum Toxin for the Treatment of Involuntary Movement DisordersRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Genetic Studies of Lysosomal Storage DisordersEnrolling By Invitation · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland
- Stereotactic Radiosurgery for Essential Tremor and Parkinsonian TremorRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Natural History Study of SynucleinopathiesRecruiting · NYU Langone Health · Boston, Massachusetts